counsyl

Formed in 2018, Myriad Women’s Health is a combination of Counsyl, Inc. and Myriad Preventive Care, a part of Myriad Genetic Laboratories, Inc. Please follow Myriad Genetics for the latest updates.

Alliance Global (AGBL Group)

The Alliance Global - AGBL Group of companies is the largest biomedical distribution group in the Middle East, Africa, and Asia region. The group is dedicated to bringing innovative technologies and products to researchers, clinicians, and diagnostic centers in emerging healthcare markets. AGBL Group employs a team of product and commercial specialists and has more than fourteen offices across the regions; offering distribution, consulting, and product development services to manufacturers of biomedical technologies. The group’s stated mission is to improve the lives of the region’s inhabitants through novel biomedical technologies and products.

Strand Life Sciences

Strand Life Sciences is a renowned global genomics and bioinformatics software and services leader with a primary goal to make precision medicine accessible to everyone. With our presence in India and U.S., we provide proprietary bioinformatics solutions, StrandNGS for Data Analysis, and Strandomics for the variant classification to Fortune 500 Companies. Our interdisciplinary team, consisting of highly skilled professionals from diverse backgrounds in computer science, data science, software development, bioinformatics, molecular biology, genetics, curation science, translational research, and pathology, is a true reflection of our unwavering commitment to excellence in genomics.

dante genomics

Dante Genomics is a leading global genomics and precision medicine company working to deliver better healthcare and save lives with a more human approach to health. We work with customers across 97 countries and we create customized genomic analysis processes that have an impact on people’s lives. Our mission is to accelerate science for the people. We leverage genome sequencing technology and interpretation so that everyone can make informed decisions about their health and their future. We use the proprietary genomic platform, based on artificial intelligence and machine learning, capable of integrating and optimizing all resources and information, creating important synergies for our stakeholders. We also collaborate with international associations and advocacy groups to find solutions to improve the quality of life of patients. In 2019 the two founders won the EY award as "best entrepreneurs of the year" and the company took sixth place in the list of 2023 growth leaders compiled by Statista and Il Sole 24 Ore. More information is available at www.dantegenomics.com

SOPHiA GENETICS

SOPHiA GENETICS was founded in 2011 by biologists who had a vision to create a technology that could make a positive and lasting impact on the world, using data for good. We’ve built a revolutionary technology platform, SOPHiA DDM™, that rapidly distills complex data into actionable insights, enabling clinicians, researchers, and biopharma to reshape the way that we diagnose and treat cancer and rare inherited disorders. The AI fueling our platform learns from the complex genomic and multimodal data provided by our community of users to create a collective intelligence over time. By using the power of data and AI, we are expanding access to data-driven medicine and enabling the patients of today to help the patients of tomorrow. Our science is driven by unrelenting passion for our mission to transform patient care by expanding access to data-driven medicine globally. We wouldn’t be able to achieve all that we have – and all that we will – without our people, who are driven by our shared purpose to ensure that every patient worldwide has equitable access to precision medicine. Our virtues are our behaviors we exhibit every day, and our mantra “We Care” is our driving force.